Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis-Reference-Cited by-同舟云学术

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis

Published:2015-01 Issue: Volume:439 Page:219-224
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Guadagno Philip A.,Summers Bellin Erin G.,Harris William S.,Dayspring Thomas D.,Hoefner Daniel M.,Thiselton Dawn L.,Stanovick Brant,Warnick G. Russell,McConnell Joseph P.

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference34 articles.

1. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices;Contois;Clin Chem,2009

2. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number;Otvos;J Clin Lipidol,2011

3. Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement;Contois;J Clin Lipidol,2011

4. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists;Davidson;J Clin Lipidol,2011

5. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk;Sniderman;Circ Cardiovasc Qual Outcomes,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ins and outs of lipoprotein(a) assay methods;Archives of Medical Science – Atherosclerotic Diseases;2024-01-03

2. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia;Journal of Clinical Lipidology;2023-11

3. Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?;International Journal of Molecular Sciences;2023-08-29

4. On the Way to a Next-Generation Lp(a) Reference Measurement System Based on Quantitative Protein Mass Spectrometry and Molar Units;Contemporary Cardiology;2023

5. Effect of lipoprotein (a) on the analytical determination of low-density lipoprotein cholesterol (LDLc) and its influence on pharmacological treatment with atorvastatin;Scandinavian Journal of Clinical and Laboratory Investigation;2022-10-06